This live web event has ended. Thank you for attending. 0 of 2 Sessions Available MAY 20 May 20, 2020 Wed 12:00 PM EDT 1H Closed Rula A. Hajj‐Ali, MD, FACP Michael Wechsler, MD NOV 12 November 12, 2020 Thu 4:00 PM EST 1H Closed Rula A. Hajj‐Ali, MD, FACP Michael Wechsler, MD Contributors Rula A. Hajj‐Ali, MD, FACP Associate DirectorCenter for Vasculitis Care and ResearchCleveland ClinicProfessor of MedicineCleveland Clinic Lerner College of Medicine Cleveland, OHRula A. Hajj‐Ali, MD, FACP is a Professor of Medicine and Staff Physician at the Center for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Disease, as well as Associate Director of the Vasculitis Center, at the Cleveland Clinic. She is board-certified in internal medicine and rheumatology.Dr. Hajj-Ali is a graduate of the American University of Beirut Medical School in Lebanon. She performed her internal medicine training at Strong Memorial Hospital in Rochester, NY and at the Cleveland Clinic, followed by a fellowship in rheumatic and immunologic disease at the American University of Beirut and the Department of Rheumatic and Immunologic Diseases at the Cleveland Clinic. She joined the staff at the Cleveland Clinic in 2002.Dr. Hajj-Ali has a particular interest in systemic inflammatory disease and vascular inflammatory disease, including systemic vasculitides, central nervous system (CNS) vasculitis, and inflammatory eye disease. Dr. Hajj-Ali is the Director of the Multidisciplinary CNS Vasculitis Clinic, which is a highly qualified multidisciplinary clinic that evaluates and treats patients with this tremendously challenging disease. She has presented her research findings at various national and international scientific meetings and her work has been published in leading professional and scientific journals.She holds the Alpha Omega Alpha honor, was elected as one of “America’s Top Physicians,” and received the Cleveland Society of Rheumatology Best Fellow Award, as well as the Clinical Research Award from the American Heart Association. Dr. Hajj-Ali is a member of numerous societies, including the American College of Rheumatology and American College of Physicians. She has served on the Planning Committee for the American College of Rheumatology Annual Meeting and is a consultant for the Vasculitis Foundation. Michael Wechsler, MD Professor of MedicineDirector, NJH Cohen Family Asthma InstituteDepartment of MedicineNational Jewish HealthDenver, COMichael Wechsler, MD is Director of the National Jewish Health (NJH)/Cohen Family Asthma Institute and Professor of Medicine in the Division of Pulmonary, Critical Care, and Sleep Medicine at NJH in Denver, CO. His research focuses on clinical and translational asthma with an emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome [CSS]). He has led several studies focusing on novel biologic agents for asthma and related diseases, and has published more than 180 peer-reviewed manuscripts relating to asthma, CSS and eosinophilic lung diseases.Dr. Wechsler was a member of the Steering Committee and site Principal Investigator (PI) for the NIH-sponsored Asthma Clinical Research Network (ACRN, now called AsthmaNet), a multi-center asthma clinical-trials consortium. He serves as the PI of the Denver site of the Precision Intervention in Severe/Exacerbating Asthma (PRECISE) network. A member of the American Society of Clinical Investigation, Dr. Wechsler has participated in many different task forces related to the study of eosinophilic lung diseases that were sponsored by the NIH, the FDA, the European Respiratory Society, and the International Eosinophil Society. He is currently Associate Editor of the journal Chest and has served as Associate Editor of Allergy and on the editorial board of the European Journal of Clinical Investigation.Dr. Wechsler received AB and MMSc degrees from Harvard University in Boston and his medical doctorate from McGill University in Montreal. He completed medical training at Beth Israel Hospital in Boston, and as part of the Harvard Combined Pulmonary and Critical Care Fellowship Training Program.